• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    6.24 0.10(1.50%) Dec 19, 4:00PM EST
    Add to Portfolio
    Prev Close:6.34
    Open:6.32
    Bid:5.50 x 500
    Ask:8.85 x 400
    1y Target Est:11.56
    Beta:1.79
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:6.18 - 6.55
    52wk Range:5.31 - 33.70
    Volume:941,390
    Avg Vol (3m):1,116,050
    Market Cap:260.27M
    P/E (ttm):23.28
    EPS (ttm):0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ECYTDown 1.50%260.27M
    NKTR2.02B
    RHHBY234.22B
    SNSS156.73M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.05
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback